REGN   $961.26  3.60% Market Closed After Close 967.89 0.69%

Regeneron Pharmaceuticals, Inc.

EMA (20): 2026-10-14 the price crossed up the moving average line and demonstrates a strong upside trend.

EMA (50): 2026-10-14 the price crossed up the moving average line and demonstrates a strong upside trend.

EMA (100): 2026-10-09 the price crossed up the moving average line and demonstrates a strong upside trend.

RSI: RSI indicator is in the upper part of the neutral territory and it heading north. These factors indicate that positive dynamics is recovering. Last signal: entrance to the overbought zone.

MACD: Oscillator MACD is in the positive territory it's higher than the signal line and grows. These factors mean that positive mood prevails. Last signal: entrance to the overbought zone.

Stochastic: The stochastic indicator is in overbought territory and it grows. These factors indicate that the upside potential still holds even though the market is overbought. Last signal: entrance to the overbought zone.

Trend Type turning up
Power strong
Trend Pattern
EMA (20) Signals bullish reversal
EMA (20) Yield 23.84%
EMA (20) date of signal Oct. 14, 2026, 3 a.m.
EMA (50) Signals bullish reversal
EMA (50) Yield 23.84%
EMA (50) date of signal Oct. 14, 2026, 3 a.m.
EMA (100) Signals bullish reversal
EMA (100) Yield 29.12%
EMA (100) date of signal Oct. 9, 2026, 3 a.m.
RSI Signals bullish recovery
RSI (14) Yield 0.0
RSI (14) date of signal Nov. 2, 2026, 3 a.m.
MACD Signals bullish
MACD Yield 19.64%
MACD date of signal Oct. 21, 2026, 3 a.m.
Stochastic Signals bullish
Stochastic Yield 17.73%
Stochastic date of signal Oct. 29, 2026, 3 a.m.
Updated Nov. 2, 2026, 11:02 p.m.